Adaptimmune vs Allogene Therapeutics
Adaptimmune
Designing and delivering cell therapies to transform the lives of people with cancer
200 employees · est. 2008 · Abingdon, United Kingdom
Allogene Therapeutics
A biotechnology company catalyzing cancer treatment through the development of CAR T therapy
214 employees · est. 2017 · South San Francisco, United...
Adaptimmune is the older company (2008 vs 2017); Allogene Therapeutics is the larger of the two.
Side-by-Side Comparison
| Metric | Adaptimmune | Allogene Therapeutics |
|---|---|---|
| Founded | ||
| Founded | 2008 older | 2017 |
| Headquarters | ||
| Headquarters | Abingdon, United Kingdom | South San Francisco, United States |
| Employees | ||
| Employees | 200 | 214 larger |
| Industry | ||
| Industry | Biopharma, Biotechnology, Health Care | Biotechnology |
| Funding Stage | ||
| Funding Stage | Post-IPO Debt | IPO |
| Total Funding | ||
| Total Funding | $499.50M | $1.05B |
| Funding Rounds | ||
| Funding Rounds | 9 | 4 |
| Services | ||
| Services | Development of T-cell therapies, Pipeline management of cell therapies, Sale and licensing of cell therapies, Biotechnological research, Clinical trials | Development of CAR T cell products, Clinical trial management, Gene editing and engineering, Manufacturing of allogeneic therapies, Therapeutic innovation for cancer and autoimmune diseases |
| Target Customers | ||
| Target Customers | Cancer patients, Healthcare professionals, Biopharmaceutical companies, Medical researchers | Patients with blood cancers, Patients with solid tumors, Patients with autoimmune diseases, Healthcare providers, Biopharmaceutical partners |
| Taxonomy | ||
| Taxonomy | Cell TherapyCancer TreatmentT Cell TherapiesPreclinical ResearchClinical DevelopmentTranslational Sciences +8 | Clinical-stageCancer TreatmentImmunotherapyCAR T TherapyAlloCAR T ProductsAllogeneic Therapies +7 |
| Website | ||
| Website | adaptimmune.com | allogene.com |
About Adaptimmune
Adaptimmune stands as a pioneering entity in the biopharmaceutical landscape, specializing in cell therapies designed to revolutionize cancer treatment. With its strong presence in four biotechnology hubs across the U.K. and U.S., the company showcases comprehensive competencies ranging from preclin...
About Allogene Therapeutics
Allogene Therapeutics, based in South San Francisco, is a clinical-stage biotechnology company spearheading the evolution of cancer treatment with its innovative AlloCAR T products. Founded in 2017, the company is at the forefront of developing allogeneic chimeric antigen receptor T cell therapies,...
Also comparing in this category
Comparing more than these two?
Get Adaptimmune, Allogene Therapeutics and up to nine more competitors side by side in one PDF: team, funding, traffic and every dated move of the last six months. Every company is re-checked on the day you order.
How does Adaptimmune compare?
A PDF of Adaptimmune and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.
This takes a few seconds: we look beyond our own index too.
Rival Readout
Comparing competitors? We do this properly.
10 rivals, 90 days of dated moves in 7 business days: a ranked list of what matters, each with its source, ending in a 60-minute readout with your team.
Frequently Asked Questions
Compare Adaptimmune with someone else
Start typing a company name or domain.
Compiled from the BounceWatch company index. We last looked at Adaptimmune on 11 Mar 2026, and Allogene Therapeutics on 9 Jun 2026. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.
